Semaglutide is a GLP-1 receptor agonist, while Tirzepatide is a dual agonist for GLP-1 & GIP receptors
Since the use of these injections is mainly in an off-label fashion, meaning not approved by the FDA, you should only seek out a medical office that has experience administering this powerful antioxidant to make sure it is administered safely, with a sterile technique, at the proper dosing, and the correct frequency
In a large U.S
: GLP training emphasizes ethical practices in laboratory research, including animal welfare, human subject protections (if applicable), and maintaining scientific integrity
The full pricing breakdown, including dose escalation, is only revealed during checkout after youve completed the entire intake process
Tirzepatide: Dual GIP and GLP-1 Activation Tirzepatide activates two appetite-related hormone signals instead of one